Transthoracic Dobutamine Stress Echocardiography in Patients Undergoing Bariatric Surgery

Thom T, Haase N, Rosamond W et al. Heart disease and stroke statistics–2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006; 113: e85–151.

Must A, Spadano J, Coakley EH et al. The disease burden associated with overweight and obesity. JAMA 1999; 282: 1523–9.

Weiss R, Dziura J, Burgert TS et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–74.

Fontaine KR, Redden DT, Wang C et al. Years of life lost due to obesity. JAMA 2003; 289: 187–93.

Steinbrook R. Surgery for severe obesity. N Engl J Med 2004; 350: 1075–9.

McTigue KM, Harris R, Hemphill B et al. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003; 139: 933–49.

Buchwald H, Avidor Y, Braunwald E et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724–37.

Dixon JB, Dixon ME, O’Brien PE. Depression in association with severe obesity: changes with weight loss. Arch Intern Med 2003; 163: 2058–65.

Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005; 294: 1909–17.

Kertai MD, Boersma E, Bax JJ et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003; 89: 1327–34.

Das MK, Pellikka PA, Mahoney DW et al. Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients. J Am Coll Cardiol 2000;35:1647–53.

Madu EC. Transesophageal dobutamine stress echocardiography in the evaluation of myocardial ischemia in morbidly obese subjects. Chest 2000; 117: 657–61.

Bhat G, Daley K, Dugan M et al. Preoperative evaluation for bariatric surgery using transesophageal dobutamine stress echocardiography. Obes Surg 2004; 14: 948–51.

Picano E, Mathias W Jr, Pingitore A et al. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994; 344: 1190–2.

Daly AL, Linares OA, Smith MJ et al. Dobutamine pharmacokinetics during dobutamine stress echocardiography. Am J Cardiol 1997; 79: 1381–6.

Cheymol G. Clinical pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet 1993; 25: 103–14.

Patel KR, White SC, Tejirian T et al. Gallbladder management during laparoscopic Rou-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surgeon 2006; 72: 857–61.

Papasavas PK, Gagne DJ, Ceppa FA et al. Routine gallbladder screening not necessary in patients undergoing laparoscopic Rou-en-Y gastric bypass. Surg Obes Relat Dis 2006; 2: 41–7.

Ramaswamy A, Gonzalez R, Smith CD. Extensive preoperative testing is not necessary in morbidly obese patients undergoing gastric bypass. J Gastrointest Surg 2004; 8: 159–64.

Smith SC Jr. Current and future directions of cardiovascular risk prediction. Am J Cardiol 2006; 97: 28A–32A.

Lopez-Jimenez F, Bhatia S, Collazo-Clavell ML et al. Safety and efficacy of bariatric surgery in patients with coronary artery disease. Mayo Clin Proc 2005; 80: 1157–62.

Ponce J, Paynter S, Fromm R. Laparoscopic adjustable gastric banding: 1,014 consecutive cases. J Am Coll Surg 2005; 201: 529–35.

Mokdad AH, Ford ES, Bowman BA et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76–9.

O’Keeffe T, Patterson EJ. Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004; 14: 23–6.